Methyl6-bromo-8-fluoro-quinoline-3-carboxylate, 98%, 1g

Diisopropyl ether, min. 98%, for synthesis, stab., 25 l, whitbl.

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinazoline, 95.0%, 1g

Tetrabutylammonium Hydroxide (10% in Methanol)100mL

METHYL 6-BROMO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 1g

1,3-Oxathiolane-2-carboxylic acid, 5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester, (2S,5R)-, 100g

2-((tert-Butoxycarbonyl)amino)-7-oxaspiro[3.5]nonane-2-carboxylic acid, 98%, 250mg

4-BROMO-3,5-DIMETHYL-1-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-PYRAZOLE, 95.0%, 1g

CIPROFLOXACIN HYDROCHLORIDE, 95%, 500mg

N-[3-Cyano-4,5-dimethyl-1-(2,4,6-trimethyl-phenyl) 1H-pyrrol-2-yl]-acetamide, 95.0%, 5g

2-Bromo-1,2-diphenylethanone, 95.0%, 25g

4-chloro-3'-(1,3-dioxolan-2-yl)-2-fluorobenzophenone, 97.0%, 1g

2,2,2-Triphenylacetophenone>99.0%(GC)5g